This week we sit down with Oliver Eng, MD, FACS, FSSO to discuss heated intraperitoneal chemotherapy (HIPEC). Dr. Eng is a surgical oncologist and an Associate Professor in the Division of Surgical Oncology at the University of California, Irvine, where he is also Associate Director of the Peritoneal Surface Malignancy Program as well as the Complex General Surgical Oncology Fellowship. He is a double board-certified surgeon and surgical oncologist who specializes in the treatment of cancers in the abdomen, particularly cancers that have spread to the peritoneum, the membrane that lines the abdominal cavity. He specializes in complex cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC).
Dr. Eng has co-authored numerous peer-reviewed manuscripts in journals including Cancer Discovery, Journal of Clinical Oncology, Cancer, and British Journal of Cancer. He has received numerous teaching and research awards and was most recently a recipient of The Lynx Group’s 40 Under 40 in Cancer Award, which recognizes the contributions being made across the field of cancer by emerging leaders nationally.